Publication | Open Access

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

Her PathwayMedicinePharmacologyPathologyColorectal CancerMetastatic Colorectal CancerMulti-drug InhibitionAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology